Cristin

2019
1.	Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Smeland, Knut Bjøro; Wilsgaard, Tom; Kiserud, Cecilie E.. Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. Acta Oncologica 2019 s. 1-11 HAUKELAND NTNU OUS STO UiO UiT UNN Untitled
2018
2.	Gunther, Oliver P; Gardy, Jennifer L; Stafford, Phillip; Fluge, Øystein; Mella, Olav; Tang, Patrick; Miller, Ruth R; Parker, Shoshana M; Johnston, Stephen A; Patrick, David M. Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Molecular Neurobiology 2018 s. 1-9 HAUKELAND Untitled

3.	Rekeland, Ingrid Gurvin; Fluge, Øystein; Alme, Kine; Risa, Kristin; Sørland, Kari; Mella, Olav; de Vries, Annick; Schjøtt, Jan. Rituximab serum concentrations and anti-rituximab antibodies during B-cell depletion therapy for myalgic encephalopathy/chronic fatigue syndrome. Clinical Therapeutics 2018 ;Volum 1. s. 9- HAUKELAND UiB Untitled

4.	Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten; Aspelin, Trude; Bersvendsen, Hanne Skjerven; Bolstad, Nils; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Holte, Harald; Lund, May-Brith; Murbræch, Klaus; Reinertsen, Kristin Valborg; Stenehjem, Jo Steinson; Kiserud, Cecilie E.. Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity. Bone Marrow Transplantation 2018 s. 1-4 KREFTREG NTNU OUS STO UiB UiO UNN Untitled

5.	Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav. Kronisk utmattelsessyndrom og pyruvat dehydrogenasefunksjon. Tidsskrift for Den norske legeforening 2018 ;Volum 138.(1) s. 12-13 HAUKELAND UiB Untitled
2017
6.	Fluge, Øystein; Mannsåker, Bård; Torp, Anders; Mjaaland, Ingvil; Helgeland, Lars; Klos, Jan; Mella, Olav; Berentsen, Sigbjørn; Meyer, Peter Albert. Consolidative radiotherapy to residual masses after chemotherapy is associated with improved outcome in diffuse large B-cell lymphoma. A retrospective, population-based study. Clinical Lymphoma, Myeloma & Leukemia 2017 ;Volum 18.(2) s. 125-135 HAUKELAND HELSEFONNA NLSH SSHF SUS Untitled

7.	Stensland, Marius; Klos, Jan; Fluge, Øystein; Helgeland, Lars; Meyer, Peter Albert. Extranodal NK/T-cell lymphoma, nasal type, primarily involving ovary. Human Pathology: Case Reports 2017 ;Volum 9. s. 58-60 HAUKELAND SUS Untitled

8.	Tronstad, Karl Johan; Fluge, Øystein; Lien, Katarina; Sommerfelt, Kristian; Mella, Olav. Mer om pyruvat dehydrogenase og kronisk utmattelsessyndrom.. Tidsskrift for Den norske legeforening 2017 UiB UiO Untitled

9.	Tronstad, Karl Johan; Fluge, Øystein; Mella, Olav. Chronic fatigue syndrome and pyruvate dehydrogenase function.. Tidsskrift for Den norske legeforening 2017 UiB Untitled
2016
10.	Christoffersen, Thoralf; Bruserud, Øystein; Fluge, Øystein; Lehne, Gustav; Dahl, Olav. Kreftbiologi og medikamentell terapi. I: Medikamentell kreftbehandling - Cytostatikaboken 8. utgave 2016. : Avdeling for farmakologi, Universitetet i Oslo 2016 ISBN 978-82-992331-4-9. s. 13-46 OUS UiB UiO Untitled

11.	Dale, Jon Espen; Sebjørnsen, Sigrunn; Leh, Sabine Maria; Røsler, Cornelia; Aaserud, Stein; Møller, Bjørn; Fluge, Øystein; Erichsen, Christian; Nadirpour, Saied; Kørner, Hartwig; Pfeffer, Frank; Dahl, Olav. Multimodal therapy is feasible in elderly anal cancer patients. Acta Oncologica 2016 ;Volum 56.(1) s. 81-87 HAUKELAND HELSEFONNA KREFTREG SUS UiB Untitled

12.	Fluge, Øystein; Mella, Olav; Bruland, Ove; Risa, Kristin; Dyrstad, Sissel Elisabeth; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Røsland, Gro Vatne; Fosså, Alexander; Ktoridou-Valen, Irini; Lunde, Sigrid; Sørland, Kari; Lien, Katarina; Herder, Ingrid; Thurmer, Hanne; Gotaas, Merete E; Baranowska, Katarzyna Anna; Bohnen, Louis M.L.J.; Schäfer, Christoph; Mccann, Adrian; Sommerfelt, Kristian; Helgeland, Lars; Ueland, Per Magne; Dahl, Olav; Tronstad, Karl Johan. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.. JCI Insight 2016 ;Volum 1. HAUKELAND OUS STHF UiB UiO UiT Untitled

13.	Fluge, Øystein; Thurmer, Hanne. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight 2016 ;Volum 1.(21) STHF UiB Untitled

14.	Kiserud, Cecilie E.; Fagerli, Unn-Merete; Smeland, Knut Bjøro; Fluge, Øystein; Bersvendsen, Hanne; Kvaløy, Stein Olav; Holte, Harald; Dahl, Alv A. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncologica 2016 ;Volum 55.(5) s. 547-553 HAUKELAND NTNU OUS STO UiO UNN Untitled

15.	Loebel, Madlen; Grabowski, Patricia; Heidecke, Harald; Bauer, Sandra; Hanitsch, Leif G.; Wittke, Kirsten; Meisel, Christian; Reinke, Petra; Volk, Hans-Dieter; Fluge, Øystein; Mella, Olav; Scheibenbogen, Carmen. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain, behavior, and immunity 2016 ;Volum 52. s. 32-39 HAUKELAND UiB Untitled

16.	Lunde, Sigrid; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Risa, Kristin; Dahl, Olav; Bruland, Ove; Mella, Olav; Fluge, Øystein. Serum BAFF and APRIL levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome. PLoS ONE 2016 ;Volum 11:e0161226.(8) HAUKELAND UiB Untitled

17.	Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Østenstad, Bjørn; Kvaløy, Stein Olav; Holte, Harald. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. British Journal of Haematology 2016 ;Volum 173.(3) s. 432-443 HAUKELAND NTNU OUS STO UiO UNN Untitled
2015
18.	Fluge, Øystein; Risa, Kristin; Lunde, Sigrid; Alme, Kine; Rekeland, Ingrid Gurvin; Sapkota, Dipak; Kristoffersen, Einar Klæboe; Sørland, Kari; Bruland, Ove; Dahl, Olav; Mella, Olav. B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PLoS ONE 2015 ;Volum 10:e0129898.(7) HAUKELAND UiB Untitled

19.	Pulczynski, Elisa J.; Kuittinen, Outi; Erlanson, Martin; Hagberg, Hans; Fosså, Alexander; Eriksson, Mikael; Nordström, Marie; Østenstad, Bjørn; Fluge, Øystein; Leppä, Sirpa; Fiirgaard, Bente; Bersvendsen, Hanne; Fagerli, Unn-Merete. Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group. Haematologica 2015 ;Volum 100.(4) s. 534-540 HAUKELAND NTNU OUS STO UNN Untitled

20.	Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Kvaløy, Stein Olav; Holte, Harald. Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. Haematologica 2015 ;Volum 100.(6) s. e240-e243 HAUKELAND NTNU OUS STO UiO UNN Untitled
2014
21.	Taskinen, Minna; Louhimo, Riku; Koivula, Satu; Chen, Ping; Rantanen, Ville; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Fjordén, Karin; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppä, Sirpa. Deregulation of COMMD1 is associated with poor prognosis in diffuse large B-cell lymphoma. PLoS ONE 2014 ;Volum 9.(3:e91031) HAUKELAND OUS Untitled
2013
22.	Holte, Harald; Leppä, Sirpa; Bjørkholm, Mikaela; Fluge, Øystein; Jyrkkio, S.; Delabie, Jan; Sundström, C.; Karjalainen-Lindsberg, Marja-Liisa; Erlanson, M.; Kolstad, Arne; Fosså, Alexander; Østenstad, Bjørn; Löfvenberg, E.; Nordstrøm, Marianne; Janes, R.; Pedersen, L.M.; Anderson, H.; Jerkeman, M.; Eriksson, M.. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. Annals of Oncology 2013 ;Volum 24.(5) s. 1385-1392 HAUKELAND OUS Untitled

23.	Knudsen-Baas, Kristin Marie; Moen, Gunnar; Fluge, Øystein; Storstein, Anette. Pseudoprogression in high-grade glioma. Acta Neurologica Scandinavica 2013 ;Volum 127. s. 31-37 HAUKELAND Untitled

24.	Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Fluge, Øystein; Fosså, Alexander; Hammerstrøm, Jens; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Østenstad, Bjørn; Kvaløy, Stein Olav; Holte, Harald. High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. Tidsskrift for Den norske legeforening 2013 ;Volum 133.(16) s. 1704-1709 NTNU OUS UiB UiO UNN Untitled
2012
25.	Leppä, Sirpa; Taskinen, Minna; Koivula, Satu; Chen, Ping; Louhimo, Riku; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Moeller; Rydström, Karin; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Holte, Harald. Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma. Journal of Clinical Oncology 2012 ;Volum 30.(15) s. - OUS UiB Untitled

26.	Myklebust, Mette Pernille; Fluge, Øystein; Immervoll, Heike; Skarstein, Arne; Balteskard, Lise; Bruland, Ove; Dahl, Olav. Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. British Journal of Cancer 2012 ;Volum 106.(4) s. 756-762 HAUKELAND UiB UNN Untitled

27.	Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H.; Rui, Hallgeir; Knudsen, Erik S.; Elsaleh, Hany; Fluge, Øystein; Vonen, Barthold; Myrvold, Helge Elliot; Leh, Sabine; Tveit, Magne Kjell; Pestell, Richard G.; Dahl, Olav. Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer 2012 ;Volum 107.(10) s. 1684-1691 HAUKELAND OUS STO UiB UiO UNN Untitled

28.	Riihijärvi, Sari; Nurmi, Heidi; Holte, Harald; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Rydström, Karin; Jerkeman, Mats; Eriksson, Mikael; Leppä, Sirpa. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy. European Journal of Haematology 2012 ;Volum 89.(5) s. 395-402 HAUKELAND OUS Untitled
2011
29.	Eide, Marianne Brodtkorb; Lauritzsen, Grete Fossum; Kvalheim, Gunnar; Kolstad, Arne; Fagerli, Unn-Merete; Maisenhölder, Martin; Østenstad, Bjørn; Fluge, Øystein; Delabie, Jan; Aarset, Harald; Liestøl, Knut; Holte, Harald. High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. British Journal of Haematology 2011 ;Volum 152.(5) s. 600-610 HAUKELAND OUS STO UiO UNN Untitled

30.	Fluge, Øystein; Bruland, Ove; Risa, Kristin; Storstein, Anette; Kristoffersen, Einar Klæboe; Sapkota, Dipak; Næss, Halvor; Dahl, Olav; Nyland, Harald Inge; Mella, Olav. Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS ONE 2011 ;Volum 6.(10) s. - HAUKELAND UiB Untitled

31.	Holte, Harald; Bogsrud, Trond; Leppa, S.; Laukka, M.; Bjørkholm, Mikaela; Jacobsson, H.; Jyrkkio, S.; Seppanen, M.; Jerkeman, Mats; Brun, E.; Fluge, Øystein; Pedersen, Lone Møller. (18)FDG PET/CT AFTER INTENSIFIED CHEMO-IMMUNOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), AGED 18-65 YEARS WITH AAIPI 2-3. POSITIVE OR INDETERMINATE LESIONS HAVE A LOW POSITIVE PREDICTIVE VALUE. A NORDIC PHASE II SUBSTUDY. Annals of Oncology 2011 ;Volum 22. s. 159-159 HAUKELAND OUS UiO Untitled

32.	Myklebust, Mette Pernille; Bruland, Ove; Fluge, Øystein; Skarstein, Arne; Balteskard, Lise; Dahl, Olav. MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. British Journal of Cancer 2011 ;Volum 105.(11) s. 1719-1725 HAUKELAND UiB UNN Untitled
2010
33.	Dresemann, Gregor; Weller, Michael; Rosenthal, Mark A.; Wedding, Ulrich; Wagner, Wolfgang; Engel, Erik; Heinrich, Bernhard; Mayer-Steinacker, Regine; Karup-Hansen, Anders; Fluge, Øystein; Nowak, Anna; Mehdorn, Maximillian; Schleyer, Eberhard; Krex, Dietmar; Olver, Ian N.; Steinbach, Joachim P.; Hosius, Christian; Sieder, Christian; Sorenson, Greg; Parker, Richard D.; Nikolova, Zariana. Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. Journal of Neuro-Oncology 2010 ;Volum 96.(3) s. 393-402 HAUKELAND Untitled

34.	Holte, Harald; Leppä, Sirpa; Björkholm, Magnus; Fluge, Øystein; Jyrkkio, Sirkku; Delabie, Jan; Sundström, Christer; Karjalainen-Lindsberg, Marja-Liisa; Erlanson, Martin; Kolstad, Arne; Fosså, Alexander; Østenstad, Bjørn; Löfvenberg, Eva; Nordström, Marie; Pedersen, Lars Møller; Anderson, Harald; Jerkeman, Mats; Eriksson, Mikael. R-CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years. Blood 2010 ;Volum 116.(21) s. 1157-1157 HAUKELAND OUS Untitled

35.	Koivula, Satu; Taskinen, Minna; Chen, Ping; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppä, Sirpa. Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. Blood 2010 ;Volum 116.(21) s. 1281-1281 HAUKELAND OUS Untitled

36.	Koivula, Satu; Taskinen, Minna; Chen, Ping; Holte, Harald; Delabie, Jan; Karjalainen-Lindsberg, Marja-Liisa; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Jerkeman, Mats; Eriksson, Mikael; Hautaniemi, Sampsa; Leppä, Sirpa. Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study. Blood 2010 ;Volum 116.(21) s. 1281-1281 HAUKELAND OUS Untitled

37.	Riihijärvi, Sari; Nyman, Heidi; Holte, Harald; Björkholm, Magnus; Fluge, Øystein; Pedersen, Lars Møller; Jerkeman, Mats; Eriksson, Mikael; Leppä, Sirpa. High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Dose-Dense Chemoimmunotherapy and Systemic CNS Prophylaxis. Results From a Nordic Phase II Study. Blood 2010 ;Volum 116.(21) s. 1686-1686 HAUKELAND OUS Untitled
2009
38.	Fluge, Øystein; Gravdal, K; Carlsen, E; Carlsen, Erik; Vonen, Barthold; Kjellevold, K; Refsum, S; Lilleng, R; Eide, Tor J.; Halvorsen, TB; Tveit, KM; Tveit, Kjell Magne; Otte, AP; Akslen, LA; Dahl, O. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. British Journal of Cancer 2009 ;Volum 101.(8) s. 1282-1289 HAUKELAND OUS STO SUS UiB UiT VV Untitled

39.	Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove; Fluge, Øystein. Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. International Journal of Hyperthermia 2009 ;Volum 25.(1) s. 41-46 HAUKELAND UiB Untitled

40.	Christoffersen, Thoralf; Fluge, Øystein; Lehne, Gustav; Dahl, Olav. Kreftceller og kjemoterapi. I: Medikamentell kreftbehandling. Oslo: Farmakologisk institutt, Det medisinske fakultet, Universitetet i Oslo 2009 ISBN 978-829923312-5. s. 13-37 UiO Untitled

41.	Dahl, Olav; Fluge, Øystein; Carlsen, Erik; Wiig, Johan N; Myrvold, Helge E; Vonen, Barthold; Podhorny, Nina; Bjerkeset, Ottar; Eide, Tor Jacob; Halvorsen, T; Tveit, Kjell Magne. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group. Acta Oncologica 2009 ;Volum 48.(3) s. 368-376 HAUKELAND OUS STHF STO SUS UiO UiT VV UiB Untitled

42.	Fluge, Øystein; Mella, Olav. Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC Neurology 2009 ;Volum 9. s. - HAUKELAND UiB Untitled
2008
43.	Borkamo, Erling Dahl; Dahl, Olav; Bruland, Ove; Fluge, Øystein. Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. International Journal of Hyperthermia 2008 ;Volum 24.(5) s. 425-441 HAUKELAND UiB Untitled

44.	Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav; Akslen, Lars A.; Bruland, Ove; Dahl, Olav. Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. Radiotherapy and Oncology 2008 ;Volum 86.(3) s. 435-442 HAUKELAND UiB Untitled

45.	Bruland, Ove; Fluge, Øystein; Immervoll, Heike; Balteskard, Lise; Myklebust, Mette Pernille; Skarstein, Arne; Dahl, Olav. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. British Journal of Cancer 2008 ;Volum 98. s. 1264-1273 HAUKELAND UiB UNN Untitled

46.	Dahl, Olav; Borkamo, Erling Dahl; Fluge, Øystein. Current status of antivascular therapy and targeted treatment in the clinic. International Journal of Hyperthermia 2008 ;Volum 24.(1) s. 97-110 HAUKELAND UiB Untitled

47.	Dahl, Olav; Fluge, Øystein. Analkreft. Tidsskrift for Den norske legeforening 2008 ;Volum 128.(2) s. 198-200 HAUKELAND UiB Untitled
2006
48.	Fluge, Øystein; Bruland, Ove; Akslen, Lars A.; Lillehaug, Johan; Varhaug, Jan Erik. Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid 2006 ;Volum 16.(2) s. 161-175 HAUKELAND UiB Untitled

49.	Lillehaug, Johan; Fluge, Øystein; Varhaug, Jan Erik. Thyroid Cancer: Molecular Biology and Clinical Aspects. I: Molecular carcinogenesis and the molecular biology of human cancer. CRC Press 2006 ISBN 0-8493-1167-5. s. 431-444 HAUKELAND UiB Untitled
2004
50.	Fluge, Øystein. Gene expression in papillary thyroid carcinomas, with special reference to tyrosine kinase receptors and growth factors. Universitetet i Bergen 2004 UiB Untitled

Vis neste liste